Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease
- PMID: 9543064
- DOI: 10.1038/sj.bmt.1701139
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease
Abstract
Quantitative competitive PCR was used to monitor the quantity of cytomegalovirus (HCMV) in 1647 blood samples from 110 BMT recipients. DNAemia was detected in 49/110 (45%) of the patients, of whom 15/49 experienced HCMV disease. Peak virus load during surveillance was elevated in symptomatic (median 4.5 log10 genomes/ml) vs asymptomatic patients (median 3.6 log10 genomes/ml, P=0.002) and was also significantly elevated in HCMV seropositive recipients of seronegative marrow, (R+D-, median 5.0 log10), compared to those in the R-D- and R+D+ groups (P < 0.01 and <0.005). Odds ratios for disease per 0.25 log10 increase in viral load, recipient seropositivity and aGVHD were 1.43 (P=0.004), 6.60 (P=0.05) and 3.17 (P=0.08), respectively. In multivariate logistic regression analysis only elevated viral load remained a significant risk factor for HCMV disease. The computed disease probability viral load curve showed a rapid increase in disease risk at viral loads between 3.8 and 5.5 log10 genomes/ml in blood, and odds ratios for disease were determined for different threshold viral loads. These data demonstrate the central role of viral load in the pathogenesis of HCMV in BMT recipients and provide an additional marker for targeting and monitoring therapy.
Similar articles
-
Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation.J Med Virol. 1997 Jun;52(2):200-5. J Med Virol. 1997. PMID: 9179769
-
Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.Exp Clin Transplant. 2006 Jun;4(1):470-4. Exp Clin Transplant. 2006. PMID: 16827646
-
Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG).J Med Virol. 1999 Jun;58(2):182-7. J Med Virol. 1999. PMID: 10335868
-
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.Haematologica. 1999 Jan;84(1):71-9. Haematologica. 1999. PMID: 10091394 Review.
-
The impact of early cytomegalovirus infection and disease in renal transplant recipients.Clin Microbiol Infect. 2005 Jul;11(7):518-30. doi: 10.1111/j.1469-0691.2005.01190.x. Clin Microbiol Infect. 2005. PMID: 15966969 Review.
Cited by
-
Quantitative molecular virology in patient management.J Clin Pathol. 2000 Jan;53(1):76-83. doi: 10.1136/jcp.53.1.76. J Clin Pathol. 2000. PMID: 10767862 Free PMC article. Review. No abstract available.
-
Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.Open Forum Infect Dis. 2018 Apr 17;5(5):ofy080. doi: 10.1093/ofid/ofy080. eCollection 2018 May. Open Forum Infect Dis. 2018. PMID: 29876364 Free PMC article.
-
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study.Lancet Haematol. 2016 Mar;3(3):e119-27. doi: 10.1016/S2352-3026(15)00289-6. Epub 2016 Feb 20. Lancet Haematol. 2016. PMID: 26947200 Free PMC article.
-
Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.Bone Marrow Transplant. 2021 Apr;56(4):909-916. doi: 10.1038/s41409-020-01122-8. Epub 2020 Nov 17. Bone Marrow Transplant. 2021. PMID: 33203951
-
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.Leukemia. 2015 Oct;29(10):2062-8. doi: 10.1038/leu.2015.212. Epub 2015 Jul 31. Leukemia. 2015. PMID: 26228813 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous